[Federal Register Volume 68, Number 25 (Thursday, February 6, 2003)]
[Notices]
[Pages 6182-6183]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-2914]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 31, 2002, Cerrilliant 
Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78664, made 
application by renewal to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)...........................  I
Methcathinone (1237).......................  I
N-Ethylamphetamine (1475)..................  I
N,N-Dimethylamphetamine (1480).............  I
Aminorex (1585)............................  I
4-Methylaminorex (cis isomer) (1590).......  I
Gamma hydroxybutyric acid (2010)...........  I
Methaqualone (2565)........................  I
Alpha-Ethyltryptamine (7249)...............  I
Lysergic acid diethylamide (7315)..........  I
Tetrahydrocannabinols (7370)...............  I
Mescaline (7381)...........................  I
3,4,5-Trimethoxyamphetamine (7390).........  I
4-Bromo-2,5-dimethoxyamphetamine (7391)....  I
4-Bromo-2,5-dimethoxyphenethylamine (7392).  I
4-Methyl-2,5-dimethoxyamphetamine (7395)...  I
2,5-Dimethoxyamphetamine (7396)............  I
2,5-Dimethoxy-4-ethylamphetamine (7399)....  I
3,4-Methylenedioxyamphetamine (7400).......  I
5-Methoxy-3,4-methylenedioxyamphetamine      I
 (7401).
N-Hydroxy-3,4-methylenedioxyamphetamine      I
 (7402).
3,4-Methylenedioxy-N-ethylamphetamine        I
 (7404).
3,4-Methylenedioxymethamphetamine (7405)...  I
4-Methoxyamphetamine (7411)................  I
Bufotenine (7433)..........................  I
Diethyltryptamine (7434)...................  I
Dimethyltryptamine (7435)..................  I
Psilocybin (7437)..........................  I
Psilocyn (7438)............................  I
Acetyldihydrocodeine (9051)................  I
Benzylmorphine (9052)......................  I
Codeine-N-oxide (9053).....................  I
Dihydromorphine (9145).....................  I
Heroin (9200)..............................  I
Hydromorphinol (9301)......................  I
Methyldihydromorphine (9304)...............  I
Morphine-N-oxide (9307)....................  I

[[Page 6183]]

 
Normorphine (9313).........................  I
Pholcodine (9314)..........................  I
Acetylmethadol (9601)......................  I
Allyprodine (9602).........................  I
Alphacetylmethadol except Levo-              I
 Alphacetylmethadol (9603).
Alphameprodine (9604)......................  I
Alphamethadol (9605).......................  I
Betacetylmethadol (9607)...................  I
Betameprodine (9608).......................  I
Betamethadol (9609)........................  I
Betaprodine (9611).........................  I
Hydromorphinol (9627)......................  I
Noracymethadol (9633)......................  I
Norlevorphanol (9634)......................  I
Normethadone (9635)........................  I
Trimeperidine (9646).......................  I
Phenomorphan (9647)........................  I
Para-Fluorofentanyl (9812).................  I
3-Methylfentanyl (9813)....................  I
Alpha-methylfentanyl (9814)................  I
Acetyl-alpha-methylfentanyl (9815).........  I
Beta-hydroxyfentanyl (9830)................  I
Beta-hydroxy-3-methylfentanyl (9831).......  I
Alpha-Methylthiofentanyl (9832)............  I
3-Methylthiofentanyl (9833)................  I
Thiofentanyl (9835)........................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Phenmetrazine (1631).......................  II
Methylphenidate (1724).....................  II
Amobarbital (2125).........................  II
Pentabarbital (2270).......................  II
Secobarbital (2315)........................  II
Glutethimide (2550)........................  II
Nabilone (7379)............................  II
1-Phenylcyclohexylamine (7460).............  II
Phencyclidine (7471).......................  II
1-Piperidinocyclohexanecarbonitrile (8603).  II
Alphaprodine (9010)........................  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Diphenoxylate (9170).......................  II
Benzoylecgonine (9180).....................  II
Ethylmorphine (9190).......................  II
Hydrocodone (9193).........................  II
Levomethorphan (9210)......................  II
Levorphanol (9220).........................  II
Isomethadone (9226)........................  II
Meperidine (9230)..........................  II
Methadone (9250)...........................  II
Methadone-intermediate (9254)..............  II
Dextropropoxyphene, bulk (non-dosage forms)  II
 (9273).
Morphine (9300)............................  II
Thebaine (9333)............................  II
Levo-alphacetylmethadol (9648).............  II
Oxymorphone (9652).........................  II
Noroxymorphone (9668)......................  II
Racemethorphan (9732)......................  II
Alfentanil (9737)..........................  II
Sufentanil (9740)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of the listed 
controlled substances to make deuterated and non-deuterated drug 
reference standards which will be distributed to analytical and 
forensic laboratories for drug testing programs.
    Any other such applicant and nay person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than April 7, 2003.

    Dated: January 27, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-2914 Filed 2-5-03; 8:45 am]
BILLING CODE 4410-09-M